Skip Navigation


NDT Advance Access originally published online on April 1, 2007
Nephrology Dialysis Transplantation 2007 22(8):2239-2246; doi:10.1093/ndt/gfm141
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/8/2239    most recent
gfm141v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by LaPlante, K. L.
Right arrow Articles by Mermel, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LaPlante, K. L.
Right arrow Articles by Mermel, L. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model

Kerry L. LaPlante1,2 and Leonard A. Mermel3,4

1Department of Pharmacy Practice, University of Rhode Island, Kingston, RI 02881, 2Veterans Affairs Medical Center, 3Division of Infectious Diseases, Rhode Island Hospital, Providence, RI 02903 and 4Department of Medicine, The Warren Alpert Medical School of Brown University, Providence, RI 02912, USA

Correspondence and offprint requests to: Kerry L. LaPlante, University of Rhode Island, Veterans Affairs Medical Center (151), Research Building, 830 Chalkstone Avenue, Providence, RI 02908. Email: KerryTedesco{at}uri.edu



  Abstract

Background. Catheter lock solutions are used for prevention and management of catheter-related bloodstream infections. We investigated the activity of daptomycin and vancomycin lock solutions against Staphylococcus aureus and Staphylococcus epidermidis in an in vitro central venous catheter (CVC) model.

Methods. Biofilm-producing reference strains of S. aureus and S. epidermidis were evaluated. After 24 h of bacterial growth in a CVC model, daptomycin and vancomycin bactericidal activity (+/– preservative-containing heparin sodium) were separately evaluated as a lock solution using 0.5, 1 and 35 mg/ml. Calcium carbonate (50 mg/l) was added to all lock solutions containing daptomycin. Each CVC was drained, flushed and sonicated at 72 h to assess CFU/ml.

Results. After 72 h of exposure in the catheter lock solutions, daptomycin and vancomycin at 0.5, 1 and 5 mg/ml demonstrated bactericidal activity (>3.0 log10 CFU/ml) against S. aureus and S. epidermidis (P ≤ 0.001). Heparin lock solution alone produced a non-significant reduction in S. aureus and S. epidermidis (1.92 ± 0.07 and 1.65 ± 0.03 log10 CFU/ml, respectively). Daptomycin 5 mg/ml lock solution +/– heparin eradicated (limit of detection 2.0 log10 CFU/ml) S. epidermidis at 72 h as did the vancomycin 5 mg/ml plus heparin. S. aureus was only eradicated from the daptomycin 5 mg/ml catheter lock-solution.

Conclusions. Our CVC model demonstrated that 72 h of exposure to 5 mg/ml lock solutions of daptomycin (plus calcium), +/– heparin or 5 mg/ml of vancomycin plus heparin demonstrate promise in treating catheter infections with biofilm-producing S. epidermidis. Similarly, 5 mg/ml of daptomycin (plus calcium) as a lock solution shows great promise in treating S. aureus catheter infections.

Keywords: biofilms; catheter lock solutions; daptomycin; Staphylococcus aureus; Staphylococcus epidermidis; vancomycin

Received for publication: 18.12.06
Accepted in revised form: 22. 2.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
E. C. Weiss, A. Zielinska, K. E. Beenken, H. J. Spencer, S. J. Daily, and M. S. Smeltzer
Impact of sarA on Daptomycin Susceptibility of Staphylococcus aureus Biofilms In Vivo
Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4096 - 4102.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K. L. LaPlante and S. Woodmansee
Activities of Daptomycin and Vancomycin Alone and in Combination with Rifampin and Gentamicin against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus Isolates in an Experimental Model of Endocarditis
Antimicrob. Agents Chemother., September 1, 2009; 53(9): 3880 - 3886.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K. L. LaPlante and L. A. Mermel
In Vitro Activities of Telavancin and Vancomycin against Biofilm-Producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis Strains
Antimicrob. Agents Chemother., July 1, 2009; 53(7): 3166 - 3169.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. Steczko, S. R. Ash, D. E. Nivens, L. Brewer, and R. K. Winger
Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens)
Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1937 - 1945.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
E. C. Weiss, H. J. Spencer, S. J. Daily, B. D. Weiss, and M. S. Smeltzer
Impact of sarA on Antibiotic Susceptibility of Staphylococcus aureus in a Catheter-Associated In Vitro Model of Biofilm Formation
Antimicrob. Agents Chemother., June 1, 2009; 53(6): 2475 - 2482.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
P B. Bookstaver, J. C Williamson, B. K. Tucker, I. I Raad, and R. J Sherertz
Activity of Novel Antibiotic Lock Solutions in a Model Against Isolates of Catheter-Related Bloodstream Infections
Ann. Pharmacother., February 1, 2009; 43(2): 210 - 219.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
J. P. Fennell, M. O'Donohoe, M. Cormican, and M. Lynch
Linezolid lock prophylaxis of central venous catheter infection
J. Med. Microbiol., April 1, 2008; 57(4): 534 - 535.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.